Arctic root
Rhodiola rosea
Rhodiola rosea, a traditional medicinal plant native to mountainous regions of Europe, Asia, and North America, has been used in various herbal remedies. Traditionally, it is believed to enhance physical endurance and mental performance, though specific uses vary across different cultures and are not well-documented. Scientific evidence suggests that Rhodiola rosea may have adaptogenic properties, potentially helping the body cope with stress. However, findings are mixed and require further high-quality research for a more comprehensive understanding. A study involving soccer players indicated that supplementation with caffeine (CAF) or Rhodiola rosea (RHO), alone or in combination, showed inconsistent effects on performance metrics such as aerial duel performance and neck neuromuscular function. Another study found that rosavin from Rhodiola rosea may offer protection against alcoholic fatty liver disease by downregulating PPARG and modulating related pathways. Additionally, a four-week supplementation period was associated with improved Yo-Yo IR2 performance and decision accuracy under fatigue compared to placebo. No major safety concerns have been recorded for Rhodiola rosea. There are currently no reported drug interactions; however, given the limited research, it is advisable to consult healthcare providers before combining Rhodiola rosea with other medications or treatments.
- Best evidence
- A
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study found that R. rosea may have multi-dimensional adaptogenic effects, though further high-quality research is needed.
- The study found that caffeine (CAF) and Rhodiola rosea (RHO) supplementation, alone or in combination, showed mixed effects on soccer players' aerial duel performance and neck neuromuscular function.
- Rosavin from Rhodiola rosea showed protective effects against alcoholic fatty liver disease by downregulating PPARG and modulating related pathways.
- Four weeks of Rhodiola rosea supplementation significantly improved Yo-Yo IR2 performance and decision accuracy under fatigue compared to placebo.
Frequently asked questions
What is Arctic root?
Arctic root (Rhodiola rosea) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Arctic root?
4 sourced findings are recorded for Arctic root; the strongest carries evidence grade A. For example: The study found that R. rosea may have multi-dimensional adaptogenic effects, though further high-quality research is needed.
How strong is the evidence for Arctic root?
The strongest finding for Arctic root carries evidence grade A — strong evidence. Grades run A (strongest) to D (preliminary or traditional).
Is Arctic root safe? What are the side effects?
No major safety issues are recorded for Arctic root in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Arctic root interact with medications?
No drug interactions are recorded for Arctic root in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Arctic root?
Arctic root is also known as: Родиола розовая, Orpin rose.
Is Arctic root a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Effects of Rhodiola rosea on Physical and Decision-Making Performance in Football Players: A Randomised Controlled Trial. literature abstract metadata
- T2 Clinical evidence for the adaptogenic effects of Withania somnifera and Rhodiola rosea - A systematic review with molecular interpretation of psychometric outcomes. literature abstract metadata
- T2 Effects of Combined Caffeine and Rhodiola rosea Supplementation on Repeated Aerial Duel Performance and Neck Neuromuscular Function in Soccer Players. literature abstract metadata
- T2 Rosavin ameliorates alcoholic fatty liver disease through PPARG-dependent inhibition of the p38 MAPK and IGF-1 pathways. literature abstract metadata